Miller DS - Search Results

1

Second-line lenvatinib in patients with recurrent endometrial cancer.

Vergote I, Powell MA, Teneriello MG, Miller DS, Garcia AA, Mikheeva ON, Bidzinski M, Cebotaru CL, Dutcus CE, Ren M, Kadowaki T, Funahashi Y, Penson RT. Vergote I, et al. Among authors: miller ds. Gynecol Oncol. 2020 Mar;156(3):575-582. doi: 10.1016/j.ygyno.2019.12.039. Epub 2020 Jan 17. Gynecol Oncol. 2020. PMID: 31955859 Free article. Clinical Trial.

2

A phase II trial of leuprolide acetate in patients with advanced epithelial ovarian carcinoma. A Gynecologic Oncology Group study.

Miller DS, Brady MF, Barrett RJ. Miller DS, et al. Am J Clin Oncol. 1992 Apr;15(2):125-8. doi: 10.1097/00000421-199204000-00006. Am J Clin Oncol. 1992. PMID: 1553899 Clinical Trial.

3

The effect of naproxen on fever in patients with advanced gynecologic malignancies.

Economos K, Lucci JA 3rd, Richardson B, Yazigi R, Miller DS. Economos K, et al. Among authors: miller ds. Gynecol Oncol. 1995 Feb;56(2):250-4. doi: 10.1006/gyno.1995.1041. Gynecol Oncol. 1995. PMID: 7534741 Clinical Trial.

4

Adenovirus-based p53 gene therapy in ovarian cancer.

Santoso JT, Tang DC, Lane SB, Hung J, Reed DJ, Muller CY, Carbone DP, Lucci JA 3rd, Miller DS, Mathis JM. Santoso JT, et al. Among authors: miller ds. Gynecol Oncol. 1995 Nov;59(2):171-8. doi: 10.1006/gyno.1995.0002. Gynecol Oncol. 1995. PMID: 7590467

5

DNA flow cytometric analysis of clinical stage I endometrial carcinomas with lymph node metastases.

Coleman RL, Schink JC, Miller DS, Bauer KD, August CZ, Rademaker AW, Lurain JR. Coleman RL, et al. Among authors: miller ds. Gynecol Oncol. 1993 Jul;50(1):20-4. doi: 10.1006/gyno.1993.1157. Gynecol Oncol. 1993. PMID: 8349159

6

In vivo studies of adenovirus-based p53 gene therapy for ovarian cancer.

von Gruenigen VE, Santoso JT, Coleman RL, Muller CY, Miller DS, Mathis JM. von Gruenigen VE, et al. Among authors: miller ds. Gynecol Oncol. 1998 Jun;69(3):197-204. doi: 10.1006/gyno.1998.5010. Gynecol Oncol. 1998. PMID: 9648587

7

Phase II trial of topotecan in patients with advanced, persistent, or recurrent uterine leiomyosarcomas: a Gynecologic Oncology Group Study.

Miller DS, Blessing JA, Kilgore LC, Mannel R, Van Le L. Miller DS, et al. Am J Clin Oncol. 2000 Aug;23(4):355-7. doi: 10.1097/00000421-200008000-00009. Am J Clin Oncol. 2000. PMID: 10955863 Clinical Trial.

8

Stage IIB-IVB cervical adenocarcinoma: prognostic factors and survival.

Lea JS, Sheets EE, Wenham RM, Duska LR, Coleman RL, Miller DS, Schorge JO. Lea JS, et al. Among authors: miller ds. Gynecol Oncol. 2002 Jan;84(1):115-9. doi: 10.1006/gyno.2001.6473. Gynecol Oncol. 2002. PMID: 11748986

9

Early-stage cervical adenocarcinoma treated by surgical intent: the role of para-aortic lymph node dissection.

Lea JS, Sheets EE, Duska LR, Miller DS, Schorge JO. Lea JS, et al. Among authors: miller ds. Gynecol Oncol. 2002 Feb;84(2):285-8. doi: 10.1006/gyno.2001.6524. Gynecol Oncol. 2002. PMID: 11812088

10

Adenosquamous histology predicts poor outcome in low-risk stage IB1 cervical adenocarcinoma.

Lea JS, Coleman RL, Garner EO, Duska LR, Miller DS, Schorge JO. Lea JS, et al. Among authors: miller ds. Gynecol Oncol. 2003 Dec;91(3):558-62. doi: 10.1016/j.ygyno.2003.08.020. Gynecol Oncol. 2003. PMID: 14675676

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

729 results

Search Page

Filters